Gelteq (GELS) Cash from Investing Activities (2023 - 2025)
Gelteq's (GELS) quarterly Cash from Investing Activities came in at -$42808.7 in Q4 2025, up 80.06% year-on-year from -$23775.2 in Q4 2024, and up 80.06% quarter-over-quarter from -$214642.9 in Q4 2024.
Gelteq (GELS) Cash from Investing Activities (2023 - 2025) Analysis & Trends
Gelteq's Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$42808.7 for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 229.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -87.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -369.95 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 743.70 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 277.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -506.20 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -60.00 Mn |
| 10 | Gelteq | 660.00 | -47,901.64 | - | -42,808.72 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -42,808.72 |
| Dec 31, 2025 | -42,808.72 |
| Dec 31, 2024 | -214,642.94 |
| Dec 31, 2024 | -214,642.94 |
| Dec 31, 2023 | -52,053.85 |
| Dec 31, 2023 | -52,053.85 |